HomeInvesting News3D Systems Introduces a New Venture, Which Will Help Drug Discovery

3D Systems Introduces a New Venture, Which Will Help Drug Discovery

Published on

3D Systems (NYSE:DDD)

3D Systems (NYSE:DDD) has just announced the launch of a bioprinting firm that will be wholly owned by the company. The venture will be called Systemic Bio and will be used to expedite the discovery of novel pharmaceuticals that will help reduce or eliminate the need for animal testing.

As the first demonstration of its commitment to Systemic Bio, the 3D printing business will invest $15 million in seeds. It is anticipated that the new organization would broaden 3D Systems’ chances for expansion in the pharmaceuticals industry and provide a new income stream with the potential to reach $100 million yearly over the next five years.

Systemic Bio plans to precisely construct vascularized organ models using the sophisticated bioprinting technology offered by 3D Systems (NYSE:DDD). This will be accomplished by the use of biomaterials as well as human cells. The new company has developed an innovative organ-on-a-chip platform called h-VIOS (human vascularized integrated organ systems), using hydrogels to build complex vasculature. This platform is an organ model that is contained inside a chip. When perfused with any desired drug molecule, the organs-on-chip technology helps in the early phases of developing novel pharmaceutical drugs to research drug metabolism and its effects on healthy or sick tissue. This can be done regardless of whether the tissue is healthy or diseased.

Additionally, to bioprint extremely complex, specifically designed, vascularized tissues for h-VIOS, Systemic Bio will link its bioprinting technologies with the Print to Perfusion method offered by 3D Systems. This combination will make it possible for 3D Systems (NYSE:DDD) to create high-resolution scaffolds that exactly replicate human tissues using 3D printing technology. This novel strategy may considerably cut the exorbitant price and extensive time necessary for developing new drugs.

Taci Pereira is going to serve as the leader of Systemic Bio. The price of a share of 3D Systems (NYSE:DDD) has fallen by 69.4% during the last year.

Featured Image-  Megapixl @Haiyin

Please See Disclaimer

Latest News

The Reason Why AMC Stock Is Falling Today

AMC Stock (NYSE:AMC) On Monday morning, news of the company's newly minted AMC Preferred Equity...

Twilio Stock: The Upside of a Down Day

Twilio Stock (NYSE:TWLO) Though a new week has begun, the stock market continues to show...

The Reason Why Roblox Stock Rose Today

Roblox Stock (NYSE:RBLX) Roblox stock was up 2.5% as of 12:10 PM ET on Monday....

Apple’s Stock Price Rises Slightly as J.P. Morgan Cites Robust Demand for the iPhone 14.

Apple's Stock (NASDAQ:AAPL) Monday saw a little increase in the price of Apple's stock as...

More like this

Raytheon Stock Plunged After It Said It Won a $160 Million Contract for a Dual-Band Radar.

Raytheon Stock (NYSE:RTX) Raytheon stock declined after the company announced that it had just won...

Jblu Stock up and Joins American Airlines to Defend Their Alliance in Court

JBLU stock was up, trading at 6.99 as of 10:21 AM EDT on Monday The...

Target Stock Falls as the Retailer Promised to Provide Excellent Holiday Savings and Values.

Target Stock (NYSE:TGT) To match the excitement of holiday customers, stores have started preparing for...

Lyft Stock Drops as Ubs Lowers Its Ratings and Slashes Its Forecast

Lyft stock slightly slid to $13.72 at 10:07 AM EDT on Monday. On Monday, Lyft...

After the Gigafactory Fire, Tesla’s Stock Price Fell Dramatically. Protests in Berlin Prompt Calls to Suspend Manufacturing

Tesla's Stock (NASDAQ:TSLA) Fire at Tesla (NASDAQ:TSLA) Gigafactory Berlin on Monday reportedly prompted calls for...

Nio stock rises as firm acquires a 12% stake in an Australian lithium company, Greenwing

Nio stock was trading slightly upwards at $18.14 as of 09:38 AM EDT. According to...